Elizabeth Chalom
Pediatric Rheumatology · Saint Paul, MNNPI 1154341147
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 265 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 20.9% — the pattern of someone who eats at a lot of different presentations.
Across 265 payments — averaging $17.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$989
- Amgen$824
- E.r. Squibb & Sons, L.L.C.$482
- Antares Pharma, Inc.$296
- Pfizer$214
- Genentech USA, Inc.$177
- plus $2K from 31 others
Across 20 payments — averaging $9115.48 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- E.r. Squibb & Sons, L.L.C.$162K
- AbbVie$16K
- Novartis$4K
What the payments were for
- Food & beverage$4,723100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 42 | $989 |
| Amgen(2 entities) | 23 | $824 |
| E.r. Squibb & Sons, L.L.C. | 33 | $482 |
| Antares Pharma, Inc. | 30 | $296 |
| Pfizer | 13 | $214 |
| Genentech USA, Inc. | 12 | $177 |
| AbbVie | 11 | $158 |
| Novo Nordisk | 9 | $141 |
| Ipsen Biopharmaceuticals, Inc | 8 | $132 |
| GSK | 7 | $122 |
| Medexus Pharma, Inc. | 8 | $111 |
| AstraZeneca | 6 | $96 |
| Azurity Pharmaceuticals, Inc. | 5 | $88 |
| Neurocrine Biosciences, Inc. | 5 | $86 |
| Kyowa Kirin, Inc. | 5 | $86 |
| Tolmar, Inc. | 5 | $82 |
| Endo Pharmaceuticals Inc. | 6 | $81 |
| Biomarin Pharmaceutical Inc. | 5 | $77 |
| Rhythm Pharmaceuticals, Inc. | 4 | $59 |
| Ascendis Pharma Endocrinology Inc | 4 | $58 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $38 |
| Sobi, Inc | 2 | $36 |
| Organon | 2 | $32 |
| IBSA Pharma Inc. | 2 | $28 |
| Arbor Pharmaceuticals, Inc. | 2 | $28 |
| Albireo Pharma, Inc. | 2 | $26 |
| Tandem Diabetes Care, Inc. | 1 | $23 |
| Mirum Pharmaceuticals, Inc. | 1 | $18 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
| Travere Therapeutics, Inc. | 1 | $15 |
| Sanofi | 1 | $15 |
| Sandoz | 1 | $15 |
| Ultragenyx Pharmaceutical Inc. | 1 | $15 |
| Mylan Institutional Inc. | 1 | $15 |
| Aimmune Therapeutics, Inc. | 1 | $15 |
| Endo USA, Inc. | 1 | $14 |
| Harmony Biosciences LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few pediatric rheumatology providers in Minnesotato place this figure against a meaningful peer group, so we don't.
Other pediatric rheumatology in Saint Paul
- Zachary ShaheenMinneapolis$50K
- Mona RiskallaMinneapolis$6K
- Bryce BinstadtMinneapolis$221
- Richard VeheMinneapolis$38
- Dori AbelRochester$32
- Colleen CorrellMinneapolis$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.